AHA urges HRSA to stop Eli Lilly’s 340B claims-data submission policy from going into effect
The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and Company policy from taking effect on Feb. 1, including by “assessing civil monetary penalties for intentionally overcharging 340B …